Skip to main content

Advertisement

SpringerLink
Log in

Rheumatoid arthritis

Rheumatoid vasculitis—down but not out

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

Rheumatoid vasculitis is one of the most severe complications of rheumatoid arthritis. New data suggests that hydroxychloroquine and low-dose aspirin might be protective, but that there remains notable mortality despite intensive immunosuppression with cyclophosphamide or biologic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Voskuyl, A. E. et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case–control study. Ann. Rheum. Dis. 55, 190–192 (1996).

    Article  CAS  Google Scholar 

  2. Makol, A. et al. Vasculitis associated with rheumatoid arthritis: a case–control study. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket475.

  3. Ntatsaki, E., Mooney, J., Scott, D. G. I. & Watts, R. A. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford) 53, 145–152 (2014).

    Article  Google Scholar 

  4. Scott, D. G. & Bacon, P. A. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am. J. Med. 76, 377–384 (1984).

    Article  CAS  Google Scholar 

  5. Sokumbi, O., Wetter, D. A., Makol, A. & Warrington, K. A. Vasculitis associated with tumour necrosis factor-a inhibitors. Mayo Clin. Proc. 87, 739–745 (2012).

    Article  Google Scholar 

  6. Morris, S. J. et al. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res. (Hoboken) 63, 530–534 (2011).

    Article  CAS  Google Scholar 

  7. Bartels, C. M., Bell, C. L., Shinki, K., Rosenthal, A. & Bridges, A. J. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 49, 1670–1675 (2010).

    Article  Google Scholar 

  8. Ward, M. M. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983–2001. Arthritis Rheum. 50, 1122–1131 (2004).

    Article  Google Scholar 

  9. Edwards, C. J., Campbell, J., van Staa, T. & Arden, N. K. Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study. BMJ Open 2, e001603 (2012).

    Article  Google Scholar 

  10. Puéchal, X. et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res. (Hoboken) 64, 331–339 (2012).

    Article  Google Scholar 

Download references

Acknowledgements

R.A.W. was supported by Norfolk and Suffolk Comprehensive Research Network.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Ipswich Hospital NHS Trust, Heath Road, Ipswich, IP4 5PD, UK

    Richard A. Watts

Authors
  1. Richard A. Watts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard A. Watts.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watts, R. Rheumatoid vasculitis—down but not out. Nat Rev Rheumatol 10, 261–262 (2014). https://doi.org/10.1038/nrrheum.2014.31

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2014.31

  • Springer Nature Limited

Search

Navigation